RxDoctor Payments Data

Amy Vasilakis-Donzella, DO

Family Medicine · Wheeling, WVNPI 1619960176

Payments from drug & device makers

$579in general payments, 2019–2025

Across 40 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$68
  • Novo Nordisk$65
  • Pfizer$53
  • Lilly USA, LLC$53
  • AstraZeneca$49
  • Johnson & Johnson$47
  • plus $243 from 11 others

What the payments were for

  • Food & beverage$579100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$579 in reported general payments places this provider in the 60th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$127,844
Medicare patients
240
Services billed
1,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$68,556
MounjaroTirzepatide51$51,651
EliquisApixaban51$41,916
TrulicityDulaglutide29$31,977
Repatha SureclickEvolocumab20$26,944
JanumetSitagliptin Phos/Metformin Hcl12$19,419
JanuviaSitagliptin Phosphate15$13,560
SynthroidLevothyroxine Sodium142$9,836
Repatha SyringeEvolocumab15$8,515
Breo ElliptaFluticasone/Vilanterol17$7,222
Atorvastatin Calcium542$5,165
MitigareColchicine14$4,538
Metoprolol Succinate259$4,181
SymbicortBudesonide/Formoterol Fumarate16$4,137
DuleraMometasone/Formoterol11$3,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$53$83,62880 claims
Novo NordiskOzempic$65$68,55651 claims
PfizerEliquis, Paxlovid$53$43,34562 claims
MerckJanumet, Januvia, Dulera$68$36,65338 claims
AbbVieSynthroid$17$9,836142 claims
AstraZenecaSymbicort$49$4,13716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Wheeling

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →